Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Clinuvel Pharmaceuticals.
RELATED STOCKHEAD STORIES
Health & Biotech
Health Check: It’s a CEO changing of the guard at Mach 7 and Universal Biosensors
Health & Biotech
Health Check: ASX ‘Magnificent Seven’ rides high amidst the US healthcare mayhem
Health & Biotech
Biocurious: FDA approval remains the Holy Grail for ASX life science stocks
Health & Biotech
Health Check: Star biotech stocks are going cheap – or cheaper than they were
Health & Biotech
Biocurious: With Mayne Pharmaceuticals under takeover offer, who’s next?
Health & Biotech
Health Check: Ansell gloves up for Trump tariff threat
Health & Biotech
Health Check: Local biotech starred in 2024, but the rising tide did not lift all boats
Experts
Criterion’s small cap gems poised to star in 2025 (part one)
News
ASX Lunch Wrap: Curve ball thrown as new bank levy bites; Alderan jumps on US copper hit
Health & Biotech
Health Check: Which biotech boards are at risk of a ‘second strike’?
Health & Biotech
Health Check: Rats – and investors – are happy as Nyrada forges ahead with its first human trial
Health & Biotech
Health Check: 4D Medical investors – and burns pit victims – can breathe easier after US lung-imaging deal
Health & Biotech
Alive and Kicking: ‘We are not alone in going through a lull in markets’, says Clinuvel chair
Health & Biotech
ASX Health Stocks: Clinuvel, MedAdvisor rally after hitting high notes on profits
Health & Biotech
ASX Health Stocks: Amplia’s pancreatic cancer drug shows progress
News
ASX Small Caps Lunch Wrap: Has Japan unleashed a new colossal death robot this week?
Health & Biotech
